1o0c: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1o0c.png|left|200px]] | [[Image:1o0c.png|left|200px]] | ||
{{STRUCTURE_1o0c| PDB=1o0c | SCENE= }} | {{STRUCTURE_1o0c| PDB=1o0c | SCENE= }} | ||
===CRYSTAL STRUCTURE OF L-GLUTAMATE AND AMPCPP BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE=== | ===CRYSTAL STRUCTURE OF L-GLUTAMATE AND AMPCPP BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE=== | ||
{{ABSTRACT_PUBMED_12691748}} | {{ABSTRACT_PUBMED_12691748}} | ||
==About this Structure== | ==About this Structure== | ||
[[1o0c]] is a 2 chain structure of [[Aminoacyl tRNA Synthetase]] with sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1O0C OCA]. | |||
==See Also== | |||
*[[Aminoacyl tRNA Synthetase|Aminoacyl tRNA Synthetase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:012691748</ref><references group="xtra"/> | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
[[Category: Glutamine--tRNA ligase]] | [[Category: Glutamine--tRNA ligase]] | ||
| Line 30: | Line 21: | ||
[[Category: Amino acid specificity]] | [[Category: Amino acid specificity]] | ||
[[Category: Engineered trna]] | [[Category: Engineered trna]] | ||
[[Category: Ligase-rna complex]] | |||
[[Category: Trna-protein complex]] | [[Category: Trna-protein complex]] | ||
Revision as of 15:29, 25 July 2012
CRYSTAL STRUCTURE OF L-GLUTAMATE AND AMPCPP BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE
Template:ABSTRACT PUBMED 12691748
About this Structure
1o0c is a 2 chain structure of Aminoacyl tRNA Synthetase with sequence from Escherichia coli. Full crystallographic information is available from OCA.
See Also
Reference
- Bullock TL, Uter N, Nissan TA, Perona JJ. Amino acid discrimination by a class I aminoacyl-tRNA synthetase specified by negative determinants. J Mol Biol. 2003 Apr 25;328(2):395-408. PMID:12691748